Huazhong University Of Science And Technology
Clinical trials sponsored by Huazhong University Of Science And Technology, explained in plain language.
-
Fiber fix? inulin may supercharge GLP-1 Weight-Loss drugs for heart health
Disease control Not yet recruitingThis study tests whether taking inulin, a type of dietary fiber, can improve cholesterol and other heart-related risk factors in 600 overweight or obese adults who are already using GLP-1 medications (like semaglutide) for weight loss. Participants will take either 10 grams of in…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
AI vs. drug: can a smart lifestyle program replace Weight-Loss shots?
Disease control Not yet recruitingThis study tests whether an AI-powered lifestyle program can help adults with type 2 diabetes maintain weight loss as well as continuing the drug tirzepatide. All 400 participants first take tirzepatide for 20 weeks to lose weight. Then, those who meet goals are randomly assigned…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for hard-to-treat colon cancer: combo attack with immunotherapy and radiation
Disease control Not yet recruitingThis phase 2 study tests whether adding an immunotherapy drug (iparomlimab and tuvonralimab) and targeted radiation to a standard targeted therapy (fruquintinib) can help people with metastatic colorectal cancer that has spread to a few spots. The trial will enroll 60 adults who …
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Triple threat: new combo therapy targets Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis clinical trial is testing a new approach for people with advanced HER2-negative stomach or gastroesophageal junction cancer that cannot be removed by surgery. The treatment combines two immunotherapy drugs (iparomlimab and tuvonralimab) with standard chemotherapy (SOX) and a…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New drug stapokibart aims to ease stuffy nose in Non-Allergic rhinitis
Disease control Not yet recruitingThis clinical trial tests whether the drug Stapokibart (CM310) can relieve nasal symptoms in adults with Non-Allergic Rhinitis with Eosinophilia Syndrome (NARES). Ninety participants will receive either Stapokibart or a placebo every two weeks for 12 weeks, while also using a sta…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Acupuncture needles aim to boost IVF success in women with repeated failure
Symptom relief Not yet recruitingThis study tests whether acupuncture can increase pregnancy rates in women who have had multiple failed embryo transfers (recurrent implantation failure). 208 women aged 20-40 will receive either real indwelling intradermal needles or placebo non-penetrating needles before their …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Can acupuncture pins cure menopausal sleeplessness?
Symptom relief Not yet recruitingThis study tests if tiny thumbtack needles placed on the skin can help women going through menopause sleep better. 198 women with chronic insomnia will either get real or fake needles for 4 weeks. The goal is to see if this simple, low-risk treatment improves sleep quality and re…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
New painkiller could cut opioid use after shoulder surgery
Symptom relief Not yet recruitingThis study compares a long-acting numbing drug (liposomal bupivacaine) to the standard version for pain relief after shoulder surgery. About 60 adults aged 18-60 will receive one of the two drugs as a nerve block before surgery. Researchers will track how much opioid pain medicin…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Could a zappy headband ease shingles nerve pain?
Symptom relief Not yet recruitingThis study tests whether a non-invasive brain stimulation device can reduce the persistent nerve pain that sometimes follows a shingles infection. Researchers will compare real stimulation to a sham (fake) procedure in 94 adults who have had pain for at least 3 months. Participan…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New painkiller may cut opioid use after abdominal surgery
Symptom relief Not yet recruitingThis study tests whether a long-acting form of the painkiller bupivacaine (called liposomal bupivacaine) can reduce the need for opioid pain medicine after laparoscopic liver, gallbladder, or pancreas surgery. Sixty adults aged 18–80 will receive either the long-acting painkiller…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Can we predict dangerous side effects of immunotherapy?
Knowledge-focused Not yet recruitingThis study aims to find biological markers that can predict immune-related side effects in cancer patients receiving immune checkpoint inhibitor therapy. Researchers will collect data from 440 participants to build a model that forecasts these adverse events. The goal is to impro…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New blood test could predict pancreatic cancer return
Knowledge-focused Not yet recruitingThis study looks at a new way to detect cancer cells in the portal vein blood of people with pancreatic cancer. The goal is to see if these cells can warn early if the cancer comes back or spreads. The study will involve 20 participants and uses a special ultrasound-guided proced…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
AI tool for doctors: help or hindrance? new study investigates
Knowledge-focused Not yet recruitingThis study looks at how different features of an AI system affect the way primary care doctors diagnose and treat respiratory infections. About 3,000 doctors in China will use a web-based tool with various AI features, such as automated data entry or stepwise medication suggestio…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Million-Person study links ancient chinese medicine to modern disease prevention
Knowledge-focused Not yet recruitingThis study will follow one million adults in China aged 30 to 74 for up to 10 years. Researchers will collect health data and Traditional Chinese Medicine (TCM) body type information to see how they relate to chronic diseases like heart disease, diabetes, and cancer. The goal is …
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC